Summary & Overview
HCPCS J3230: Injection, Chlorpromazine HCl, Up to 50 mg
HCPCS Level II code J3230 denotes an injectable dose of chlorpromazine hydrochloride up to 50 mg, an antipsychotic used in acute management settings. The code is relevant nationally for billing of injectable psychotropic medication across multiple care settings, including outpatient clinics, emergency departments, and hospital outpatient departments. Accurate use of this HCPCS code affects claims processing, clinical documentation, and appropriate reimbursement for single-dose injectable chlorpromazine.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, the typical service contexts where it is used, and the payer coverage landscape. The publication summarizes benchmark considerations, payer coverage patterns, and the clinical context for using injectable chlorpromazine, including key documentation elements and common billing practices. It also notes where input data was not provided by the source.
This executive summary is intended for billing professionals, revenue cycle leaders, and clinicians who need a clear, national-level reference for HCPCS Level II code J3230 and its role in billing for injectable antipsychotic therapy.
Billing Code Overview
HCPCS Level II code J3230 represents an injection of chlorpromazine hydrochloride, up to 50 mg. This code is used to bill for administration of the antipsychotic medication chlorpromazine HCl when provided as an injectable dose not exceeding 50 mg.
Service Type: Medication administration (injectable antipsychotic)
Typical Site of Service: Outpatient clinic or hospital outpatient department, emergency department, or other settings where injectable medications are administered.
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient with a history of schizophrenia presents to the emergency department with acute agitation and severe psychomotor unrest after discontinuation of oral antipsychotic therapy. The treating team determines intramuscular antipsychotic medication is necessary for rapid tranquilization. A single-dose injection of chlorpromazine hydrochloride up to 50 mg (J3230) is prepared in the ED medication area by a licensed nurse under physician order. Vital signs and mental status are monitored before and after administration. Documentation includes the indication, dose (up to 50 mg), route (intramuscular), site of injection, informed consent or patient restraint status if applicable, monitoring of adverse effects (hypotension, sedation, anticholinergic effects), and time of administration. Billing uses the HCPCS Level II code J3230 for the drug supply; any applicable administration CPT codes and facility charges are billed separately according to payer policy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard billing when no modifier applies to the service |